Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990
In Brief: Paul Sugarbaker to Head New DC Cancer Center; Michael Shimkin Dies; Tel Aviv Conference “Safe”
Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita
New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed
Sullivan Confirmation Hearing Set For Feb. 1
USC Cancer Center Plans Expansion, Gets New Name
AACR Receives Record Number of Abstracts
Trending Stories
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years
- After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.” - Trump administration announces “major crackdown” on healthcare fraud
- FDA issues draft guidance on accelerating development of individualized therapies for ultra-rare diseases









